These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17230496)

  • 1. Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes.
    Dong M; Dong Q; Zhang H; Zhou J; Tian Y; Dong Y
    J Surg Oncol; 2007 Mar; 95(4):332-6. PubMed ID: 17230496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
    Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.
    Yamasawa K; Nio Y; Dong M; Yamaguchi K; Itakura M
    Clin Cancer Res; 2002 Aug; 8(8):2563-9. PubMed ID: 12171884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
    Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
    J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
    Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
    Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.
    Dang CX; Han Y; Qin ZY; Wang YJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):302-5. PubMed ID: 14612290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
    Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
    Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
    Tomaszewska R; Nowak K; Stachura J
    Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression as prognostic factor in human pancreatic cancer.
    Sato Y; Nio Y; Song MM; Sumi S; Hirahara N; Minari Y; Tamura K
    Anticancer Res; 1997; 17(4A):2779-88. PubMed ID: 9252715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.
    Zhang SY; Ruggeri B; Agarwal P; Sorling AF; Obara T; Ura H; Namiki M; Klein-Szanto AJ
    Arch Pathol Lab Med; 1994 Feb; 118(2):150-4. PubMed ID: 8311654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of MUC1 in advanced pancreatic cancer.
    Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S
    J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
    Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
    Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.